rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    NUVB
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Nuvation Bio at Jefferies Global Healthcare Conference: pipeline gains
      Nov 17Investing.comJEFNUVB
      Nuvation Bio (NUVB) Stock Trades Below Fair Value After Its 211% Run

      Nuvation Bio has delivered a very large 211.1% share price gain over the past three years, even as the stock has recently pulled back. That kind of longer term move puts a spotlight on a basic question for you as an investor: whether the current valuation is supported by the company’s sales profile. Over a three year window the stock is up 211.1%, so anyone looking at Nuvation Bio today needs to ask how much of its commercial potential is already reflected in the price. Recent product...

      Nov 10Yahoo FinanceNUVB
      Nuvation Bio: The Market Is Counting New Starts While IBTROZI Stacks Patients (NUVB)
      Nov 9Seeking AlphaNUVB
      What Nuvation Bio (NUVB) Said on Its Q3 Earnings Call
      Nov 8Yahoo FinanceNUVB
      Nuvation Bio (NUVB) Q3 2026 Earnings Call Transcript

      Motley Fool Press Release.

      Nov 5The Globe and MailNUVB
      Nuvation Bio Inc (NUVB) Q3 2026 Earnings Call Highlights: IBTROZI Revenue Climbs 18% as ...
      Nov 5Yahoo FinanceNUVB
      Nuvation Bio Q3 2026 Earnings Call Transcript
      Nov 4BenzingaNUVB
      Nuvation Bio earnings matched, revenue topped estimates
      Nov 4Investing.comNUVB
      Nuvation Bio Inc. (NUVB) Reports Q3 Loss, Beats Revenue Estimates
      Nov 4Yahoo FinanceNUVB
      Nuvation Bio earnings in focus as drug launch faces first test
      Nov 4Investing.comNUVB
      Nuvation Bio to present phase 2 data at neuro-oncology meeting
      Nov 2Investing.comNUVB
      Nuvation Bio expands glioma drug trial to six European nations
      Oct 29Investing.comNUVB
      Nuvation Bio to Report Third Quarter 2026 Financial Results and Provide Business Update on November 4, 2026
      Oct 21Yahoo FinanceNUVB
      Citizens reiterates Nuvation Bio stock rating on launch execution
      Oct 19Investing.comNUVB
      Our Pick Of The Best Penny Stocks In October 2026
      Oct 17Yahoo FinanceNUVB
      Nuvation Bio (NUVB) Gets a Buy from RBC Capital

      Tipranks Press Release.

      Oct 15The Globe and MailNUVB
      Nuvation Bio (NUVB) Receives a Buy from RBC Capital

      Detailed price information for Nuvation Bio Inc (NUVB-N) from The Globe and Mail including charting and trades.

      Oct 9The Globe and MailNUVB
      Nuvation stock, Jazz stock gain new Buys at Citi (NUVB:NYSE)

      Nuvation Bio NUVB) stock and Jazz Pharmaceuticals (JAZZ) stock gain as Citi issues new Buy ratings on the firms based on their cancer treatments. Read more here.

      Sep 30Seeking AlphaJAZZNUVB
      Citigroup Initiates Nuvation Bio at Buy With $12 Price Target

      Nuvation Bio (NUVB) has an average rating of buy and mean price target of $13.10, according to analy

      Sep 30Yahoo FinanceNUVB
      Why Is Nuvation Bio Stock Gaining Thursday?
      Sep 17BenzingaNUVB
      Nuvation Bio stock gains on FDA label update for IBTROZI
      Sep 17Investing.comNUVB
      Why is Nuvation Bio stock surging today?
      Sep 17Investing.comNUVB
      Nuvation Bio rises on FDA label update for Ibtrozi
      Sep 17Seeking AlphaNUVB
      Nuvation Bio Gets FDA Approval for Updated IBTROZI Label
      Sep 17Yahoo FinanceNUVB
      Nuvation Bio (NUVB) Reports IBTROZI Efficacy Across ROS1 Lung Cancer Subgroups

      Nuvation Bio (NYSE:NUVB) presented new subgroup analyses of IBTROZI (taletrectinib) at the 2026 World Conference on Lung Cancer. The data indicated durable and consistent efficacy in advanced ROS1+ non small cell lung cancer regardless of prior chemotherapy exposure. IBTROZI efficacy was reported as consistent across different ROS1 fusion partners in patients with advanced ROS1+ non small cell lung cancer. These IBTROZI subgroup findings matter, but investors may wish to weigh them alongside...

      Sep 16Yahoo FinanceNUVB
      Citizens maintains Nuvation Bio stock rating on competitive edge
      Sep 16Investing.comNUVB
      Nuvation Bio presents subgroup analyses for lung cancer drug
      Sep 15Investing.comNUVB
      Nuvation Bio at 12th Annual Cantor Fitzgerald Global Healthcare Conference: pipeline gains
      Sep 10Investing.comNUVB
      Nuvation Bio at citigroup biopharma summit: growth rests on three pillars
      Sep 9Investing.comNUVB
      Jim Cramer sends strong 5-word message on surging biotech stock
      Sep 6TheStreetNUVB
      Cramer's lightning round: Nuvation Bio 'is a pure spec'

      "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

      Sep 3CNBCSENEASENEBNUVBSMR
      Does Nuvation Bio (NUVB) Have the Potential to Rally 91.92% as Wall Street Analysts Expect?

      The average of price targets set by Wall Street analysts indicates a potential upside of 91.9% in Nuvation Bio (NUVB). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

      Sep 3Yahoo FinanceNUVB
      Nuvation Bio to Participate in Upcoming Investor Conferences
      Sep 2Yahoo FinanceNUVB
      Nuvation Bio (NUVB) Upgraded to Buy: Here's Why

      Nuvation Bio (NUVB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

      Aug 31Yahoo FinanceNUVB
      Nuvation: Why I'm Downgrading To Hold Despite Progress On NSCLC And Glioma Fronts (NUVB)
      Aug 26Seeking AlphaNUVB
      Why is Nuvation Bio stock rallying today?
      Aug 21Investing.comNUVB
      Nuvation Bio stock rises after Cantor starts at Overweight
      Aug 21Investing.comNUVB
      Nuvation Bio rises as Cantor initiates at overweight
      Aug 21Seeking AlphaNUVB
      Cantor Fitzgerald initiates Nuvation Bio stock with overweight rating
      Aug 21Investing.comNUVB

      This is the newest page. Registered accounts read further back.